<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01025947</url>
  </required_header>
  <id_info>
    <org_study_id>HCUV</org_study_id>
    <nct_id>NCT01025947</nct_id>
  </id_info>
  <brief_title>&quot;Cryptogenic Stroke and Atrial Fibrillation Detection Through Implantable Loop Recorder (ILR)&quot;</brief_title>
  <acronym>CRYPTONITE</acronym>
  <official_title>Observational Study on Cryptogenic Stroke and Atrial Fibrillation Detection Through Implantable Loop Recorder</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Valencia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hospital Universitario Virgen de la Arrixaca</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Universidad de Murcia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Valencia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      STUDY TYPE:

      Prospective, national , multicenter, and observational study.

      OBJECTIVE:

      To assess the incidence of AF in patients with cryptogenic stroke who have implanted an AF
      detection device during a period of 2 years.

      DEVICE:

      Reveal XT 9529 (SQDM)

      SAMPLE SIZE AND STUDY DURATION:

      100 patients enrolled which will be followed during a period of 2 years.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Observational study in patients with cryptogenic stroke (TOAST criteria) and with an
      implanted EKG loop recorder, with the primary objective of knowing the atrial fibrillation
      incidence in this population
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2009</start_date>
  <completion_date type="Anticipated">March 2013</completion_date>
  <primary_completion_date type="Anticipated">March 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>First AF episode detected by the implantable loop recorder in patients that had a cryptogenic stroke. An AF episode will be considered an AF episode that lasts at least 2 minutes.</measure>
    <time_frame>Patients will be followed up during two years, regardless of reaching or not the primary endpoint.</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>All subsequent AF episodes detected by the ILR after primary outcome (AF burden)</measure>
    <time_frame>Patients will be followed up during two years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>AF episodes detected by external monitoring</measure>
    <time_frame>Patients will be followed up during two years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Presence of stroke, recurrent TIA, or silent infarction in neuroimaging</measure>
    <time_frame>Patients will be followed up during two years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in anticoagulant therapy</measure>
    <time_frame>Patients will be followed up during two years</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Atrial Fibrillation</condition>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>Study group</arm_group_label>
    <description>Patients with cryptogenic stroke (TOAST criteria) and with an implantable EKG loop recorder implanted</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with cryptogenic stroke (TOAST criteria) and with an implantable EKG loop recorder
        implanted for detection of atrial fibrillation
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients included must meet one of these two conditions:

               -  Patient presenting with an episode of transient ischemic attack (TIA) of
                  cryptogenic origin with neurological symptoms of less than 24h of evolution and
                  negative neuroimaging.

               -  First episode of ischaemic stroke with cryptogenic etiology following TOAST
                  criteria

          -  All patients must meet all of the following:

               -  The patient has been implanted an ILR within 30 days after qualifying event

               -  Age between 45-85 years

               -  No stenosis &gt;50% in any arterial vessel corresponding to the affected territory

               -  Normal Echocardiography

               -  Normal 24 hours EKG Holter recording

               -  Absence of Patent Foramen Ovale through transcranial doppler (or transesophageal
                  echocardiography)

               -  Acceptance and signature of Patient Informed Consent.

        Exclusion Criteria:

          -  All patients included cannot meet any of the following conditions:

               -  Recurrent stroke or TIA

               -  Stroke or TIA with determined etiology according to TOAST criteria.

               -  Anticoagulation indication at the time of enrollment in the study.

               -  Total contraindication for anticoagulation therapy

               -  Atrial fibrillation detection prior to enrollment

               -  Severe cognitive impairment or dementia

               -  Patient unable to be followed up

               -  Patients enrolled in another clinical trial

               -  Patients with life expectancy of less than 1 year

               -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ricardo Ruiz-Granell, MD, Phd</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Clinico Universitario de Valencia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Arcadio Garcia-Alberola, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Hospital Universitario Virgen de la Arrixaca</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ana Morales, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Hospital Universitario Virgen de la Arrixaca</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Alejandro Ponz, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Hospital Clinico Universitario de Valencia</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ricardo Ruiz-Granell, MD, PhD</last_name>
    <phone>0034 963862658</phone>
    <email>ruiz_ric@gva.es</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Arcadio García-Alberola, MD, PhD</last_name>
    <email>arcadi@secardiologia.es</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital Universitario Virgen de la Arrixaca</name>
      <address>
        <city>Murcia</city>
        <zip>30120</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Arcadio García-Alberola, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ana Morales, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Clinico Universitario de Valencia</name>
      <address>
        <city>Valencia</city>
        <zip>46010</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Ricardo Ruiz-Granell, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alejandro Ponz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Rosamond W, Flegal K, Friday G, Furie K, Go A, Greenlund K, Haase N, Ho M, Howard V, Kissela B, Kittner S, Lloyd-Jones D, McDermott M, Meigs J, Moy C, Nichol G, O'Donnell CJ, Roger V, Rumsfeld J, Sorlie P, Steinberger J, Thom T, Wasserthiel-Smoller S, Hong Y; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2007 Feb 6;115(5):e69-171. Epub 2006 Dec 28. Erratum in: Circulation. 2007 Feb 6;115(5):e172. Circulation. 2010 Jul 6;122(1):e9. Kissela, Bret [corrected to Kissela, Brett].</citation>
    <PMID>17194875</PMID>
  </reference>
  <reference>
    <citation>Carandang R, Seshadri S, Beiser A, Kelly-Hayes M, Kase CS, Kannel WB, Wolf PA. Trends in incidence, lifetime risk, severity, and 30-day mortality of stroke over the past 50 years. JAMA. 2006 Dec 27;296(24):2939-46.</citation>
    <PMID>17190894</PMID>
  </reference>
  <reference>
    <citation>Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE 3rd. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993 Jan;24(1):35-41.</citation>
    <PMID>7678184</PMID>
  </reference>
  <reference>
    <citation>Adams HP Jr, Davis PH, Leira EC, Chang KC, Bendixen BH, Clarke WR, Woolson RF, Hansen MD. Baseline NIH Stroke Scale score strongly predicts outcome after stroke: A report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Neurology. 1999 Jul 13;53(1):126-31.</citation>
    <PMID>10408548</PMID>
  </reference>
  <reference>
    <citation>Sacco RL, Ellenberg JH, Mohr JP, Tatemichi TK, Hier DB, Price TR, Wolf PA. Infarcts of undetermined cause: the NINCDS Stroke Data Bank. Ann Neurol. 1989 Apr;25(4):382-90.</citation>
    <PMID>2712533</PMID>
  </reference>
  <reference>
    <citation>Jabaudon D, Sztajzel J, Sievert K, Landis T, Sztajzel R. Usefulness of ambulatory 7-day ECG monitoring for the detection of atrial fibrillation and flutter after acute stroke and transient ischemic attack. Stroke. 2004 Jul;35(7):1647-51. Epub 2004 May 20.</citation>
    <PMID>15155965</PMID>
  </reference>
  <reference>
    <citation>Douen AG, Pageau N, Medic S. Serial electrocardiographic assessments significantly improve detection of atrial fibrillation 2.6-fold in patients with acute stroke. Stroke. 2008 Feb;39(2):480-2. doi: 10.1161/STROKEAHA.107.492595. Epub 2008 Jan 3.</citation>
    <PMID>18174488</PMID>
  </reference>
  <reference>
    <citation>Liao J, Khalid Z, Scallan C, Morillo C, O'Donnell M. Noninvasive cardiac monitoring for detecting paroxysmal atrial fibrillation or flutter after acute ischemic stroke: a systematic review. Stroke. 2007 Nov;38(11):2935-40. Epub 2007 Sep 27. Review.</citation>
    <PMID>17901394</PMID>
  </reference>
  <reference>
    <citation>Solano A, Menozzi C, Maggi R, Donateo P, Bottoni N, Lolli G, Tomasi C, Croci F, Oddone D, Puggioni E, Brignole M. Incidence, diagnostic yield and safety of the implantable loop-recorder to detect the mechanism of syncope in patients with and without structural heart disease. Eur Heart J. 2004 Jul;25(13):1116-9.</citation>
    <PMID>15231369</PMID>
  </reference>
  <verification_date>June 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 3, 2009</study_first_submitted>
  <study_first_submitted_qc>December 3, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 4, 2009</study_first_posted>
  <last_update_submitted>June 25, 2010</last_update_submitted>
  <last_update_submitted_qc>June 25, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 28, 2010</last_update_posted>
  <responsible_party>
    <name_title>Ricardo Ruiz Granell, MD, PhD</name_title>
    <organization>Hospital Clínico Universitario de Valencia</organization>
  </responsible_party>
  <keyword>Atrial fibrillation</keyword>
  <keyword>Cryptogenic stroke</keyword>
  <keyword>Implantable loop recorder</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

